Shares of The Beauty Health Company (SKIN) are up more than 6% Thursday morning after the company announced its three-year financial targets including doubling sales by 2025.
The company has set its 2025 sales target in the range of $600 million-$700 million, about 20% - 27% 2022E - 2025E net sales CAGR. The company also expects to at least triple its adjusted EBITDA by 2025.
Further, Beauty Health Company expects to drive incremental profitability starting in 2023, with a target adjusted EBITDA margin of approximately 18% - 20%.
"We are setting thoughtful 2025 financial targets from a position of financial strength, supported by strong ongoing performance of six quarters of beating and raising as well as achieving recent record net sales," said BeautyHealth Chief Financial Officer Liyuan Woo.
SKIN, currently at $12.451, has traded in the range of $9.94-$30.17 in the past 52 weeks.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.